SPX3,685.01+37.72 1.03%
DIA294.02+2.72 0.93%
IXIC10,927.02+97.51 0.90%

-- ImmunoPrecise Brief: Reported Q1 FY23 Total revenue of $4.7 Million was an increase of $0.1 million or 2.2% as compared to total revenue of $4.6 million from the same period last year

-- ImmunoPrecise Brief: Reported Q1 FY23 Total revenue of $4.7 Million was an increase of $0.1 million or 2.2% as compared to total revenue of $4.6 million from the same period last year

MT Newswires · 09/14/2022 04:15

Please log in to view news